Nrf2 induction by treatment with Nrf2 activators could protect pancreatic β-cells from ROS-stimulated damage and effectively diminish endogenous oxidative stress to prevent the pathogenesis and progression of T1DM [15, 17, 18]. The gene discussed is NFE2L2; the disease is type 1 diabetes mellitus.